Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease



Eyers, Patrick A ORCID: 0000-0002-9220-2966
(2018) Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease. BIOCHEMICAL JOURNAL, 475 (1). pp. 185-189.

[img] Text
Eyers-2018-BiochemJournal.pdf - Published version

Download (261kB)

Abstract

The addition of phosphate groups to substrates allows protein kinases to regulate a myriad of biological processes, and contextual analysis of protein-bound phosphate is important for understanding how kinases contribute to physiology and disease. Leucine-rich repeat kinase 2 (LRRK2) is a Ser/Thr kinase linked to familial and sporadic cases of Parkinson's disease (PD). Recent work established that multiple Rab GTPases are physiological substrates of LRRK2, with Rab10 in particular emerging as a human substrate whose site-specific phosphorylation mirrors hyperactive LRRK2 lesions associated with PD. However, current assays to quantify Rab10 phosphorylation are expensive, time-consuming and technically challenging. In back-to-back studies reported in the <i>Biochemical Journal</i>, Alessi and colleagues teamed up with clinical colleagues and collaborators at the Michael J. Fox Foundation (MJFF) for Parkinson's research to develop, and validate, a panel of exquisitely sensitive phospho-specific Rab antibodies. Of particular interest, the monoclonal antibody-designated MJFF-pRAB10 detects phosphorylated Rab 10 on Thr73 in a variety of cells, brain extracts, PD-derived samples and human neutrophils, the latter representing a previously unrecognised biological resource for LRRK2 signalling analysis. In the future, these antibodies could become universal resources in the fight to understand and quantify connections between LRRK2 and Rab proteins, including those associated with clinical PD.

Item Type: Article
Uncontrolled Keywords: Humans, Parkinson Disease, Antibodies, Phospho-Specific, Biological Phenomena, Signal Transduction, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Depositing User: Symplectic Admin
Date Deposited: 01 Feb 2018 12:53
Last Modified: 13 Feb 2024 15:23
DOI: 10.1042/BCJ20170870
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3017292